US › Healthcare

Im Cannabis Corp (IMCC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.74+6.75%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$7.6M

Revenue YoY

-40.2%

Net profit

$-4.4M

EPS

$-0.34

Net margin

-57.5%

Key statistics

Market cap

$1.1M

Forward P/E

42.4

P/B

0.95

Book value

$-7.38

EPS (TTM)

$-76.42

52-week high

$65.81

52-week low

$1.73

50-day MA

$3.63

200-day MA

$19.27

Beta

2.10

Analyst view

Analysts rate Im Cannabis Corp a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $8.22.

Shareholding

Insiders

11.78%

Institutions

1.94%

Largest institutional holders

Fund	Stake
Hidden Cove Wealth Management, LLC	0.16%
Bank of Montreal	0.13%
BMO Capital Markets Corp.	0.13%
Federation des caisses Desjardins du Quebec	0.02%
NATIONAL BANK OF CANADA /FI/	0.00%
Royal Bank of Canada	0.00%
Advisor Group Holdings, Inc.	0.00%
TD Waterhouse Canada Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Im Cannabis Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.